West Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-177
Closed -$4.41K 224
2025
Q4
$4.41K Buy
+177
New +$4.46K ﹤0.01% 177
2025
Q1
Sell
-108
Closed -$2.87K 220
2024
Q4
$2.87K Buy
+108
New +$2.93K ﹤0.01% 170
2024
Q1
Sell
-591
Closed -$17K 164
2023
Q4
$17K Sell
591
-171
-22% -$5.17K ﹤0.01% 111
2023
Q3
$25.3K Buy
762
+171
+29% +$6.05K 0.01% 101
2023
Q2
$21.7K Hold
591
0.01% 106
2023
Q1
$24.1K Hold
591
0.01% 98
2022
Q4
$30.3K Hold
591
0.01% 90
2022
Q3
$26K Hold
591
0.01% 120
2022
Q2
$31K Sell
591
-137
-19% -$6.98K 0.01% 110
2022
Q1
$38K Buy
728
+137
+23% +$7.11K 0.01% 109
2021
Q4
$35K Hold
591
0.01% 119
2021
Q3
$25K Hold
591
0.01% 116
2021
Q2
$23K Hold
591
0.01% 109
2021
Q1
$21K Sell
591
-40
-6% -$1.42K 0.01% 110
2020
Q4
$23K Buy
+631
New +$23.1K 0.01% 106

Other funds holding PFE

West Financial Advisors's PFE Position: Q1 2026 in Review

West Financial Advisors sold out of Pfizer (PFE) in Q1 2026, closing a stake of 177 shares — an estimated $4.41K sold.

West Financial Advisors first reported a position in PFE in Q4 2020 and held it in 15 quarters. The position peaked at $38K in Q1 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • West Financial Advisors reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • West Financial Advisors sold 177 Pfizer shares in Q1 2026, an estimated $4.41K.
  • West Financial Advisors first reported a position in Pfizer in Q4 2020 and held it in 15 quarters.
  • West Financial Advisors's Pfizer position peaked at $38K in Q1 2022.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on West Financial Advisors's 13F filing for Q1 2026, filed 8 Apr 2026.